[go: up one dir, main page]

MX2017005373A - Soporte de biomaterial para la regeneracion de mucosa oral. - Google Patents

Soporte de biomaterial para la regeneracion de mucosa oral.

Info

Publication number
MX2017005373A
MX2017005373A MX2017005373A MX2017005373A MX2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A
Authority
MX
Mexico
Prior art keywords
hydrogel
oral mucosa
regeneration
biomaterial structure
biomaterial
Prior art date
Application number
MX2017005373A
Other languages
English (en)
Other versions
MX380173B (es
Inventor
Baiget Orts Amparo
Castro Feo Begoña
Original Assignee
Histocell Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histocell Sl filed Critical Histocell Sl
Publication of MX2017005373A publication Critical patent/MX2017005373A/es
Publication of MX380173B publication Critical patent/MX380173B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un procedimiento para preparar una estructura de biomaterial comprendiendo dicho método, (a) proporcionar un hidrogel que comprende una red de fibrina y una red de polisacárido, (b) someter el hidrogel de la etapa a) a un procedimiento de congelación-descongelación para reticular físicamente el hidrogel; y (c) someter el hidrogel reticulado físicamente obtenido tras realizar la etapa b), a una liofilización. La invención también se refiere a la estructura de biomaterial que puede obtenerse mediante el procedimiento tal como se definió anteriormente, así como a dicha estructura de biomaterial para su uso para aumentar, reestablecer o reemplazar parcial o completamente la actividad funcional de una mucosa oral enferma o dañada.
MX2017005373A 2014-10-24 2015-10-23 Estructura de biomaterial para regenerar la mucosa oral MX380173B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382417.5A EP3011981A1 (en) 2014-10-24 2014-10-24 A biomaterial scaffold for regenerating the oral mucosa
PCT/EP2015/074610 WO2016062862A1 (en) 2014-10-24 2015-10-23 A biomaterial scaffold for regenerating the oral mucosa

Publications (2)

Publication Number Publication Date
MX2017005373A true MX2017005373A (es) 2017-07-28
MX380173B MX380173B (es) 2025-03-12

Family

ID=51844651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005373A MX380173B (es) 2014-10-24 2015-10-23 Estructura de biomaterial para regenerar la mucosa oral

Country Status (11)

Country Link
US (1) US11241516B2 (es)
EP (2) EP3011981A1 (es)
JP (1) JP6633628B2 (es)
KR (1) KR102489773B1 (es)
CN (1) CN107073170B (es)
AU (1) AU2015334897B2 (es)
BR (1) BR112017008117B1 (es)
CA (1) CA2964501C (es)
ES (1) ES2774792T3 (es)
MX (1) MX380173B (es)
WO (1) WO2016062862A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3551216B1 (en) 2016-12-07 2024-07-10 Mayo Foundation for Medical Education and Research Methods and materials for using fibrin supports for retinal pigment epithelium transplantation
EP3746092B1 (en) 2018-02-01 2025-08-06 North Carolina State University Antimicrobial platelet-like particles
WO2019215557A1 (en) * 2018-05-07 2019-11-14 Reelabs Pvt. Ltd. The method of autologous primary hair follicles preparation in 3d culture
WO2020033713A1 (en) * 2018-08-08 2020-02-13 Northeastern University Oxygen-generating cryogels
CN110760076B (zh) * 2019-11-06 2022-04-08 大连理工大学 一种基于胶体颗粒-iPRF双网络结构的可注射、高强度复合水凝胶及其制备方法和应用
CN110743038B (zh) * 2019-11-06 2021-09-10 大连理工大学 一种双网络结构复合水凝胶及其制备方法和应用
WO2021108791A1 (en) * 2019-11-29 2021-06-03 North Carolina State University Neonatal fibrin scaffolds for promoting wound healing
CN110982125B (zh) * 2019-12-19 2022-01-21 武汉纺织大学 一种形状自恢复多孔复合凝胶及其制备方法与应用
CN113318275B (zh) * 2021-08-03 2021-11-02 首都医科大学附属北京口腔医院 用于牙髓牙本质再生的可降解水凝胶
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114146223A (zh) * 2021-12-10 2022-03-08 三亚悦美科技有限公司 一种重组胶原蛋白复合注射剂及其制备方法
EP4241798A1 (en) * 2022-03-11 2023-09-13 Universidad de Granada Hydrogel suitable to produce artificial tissues
IL305612B2 (en) * 2023-08-31 2025-02-01 Redefine Meat Ltd Edible scaffolds, their preparation and use
WO2025173759A1 (ja) * 2024-02-16 2025-08-21 一般社団法人日本血液製剤機構 止血、組織接着・閉鎖、細胞の足場材料等のための生体材料としてのフィブリノゲンのゲル

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
AU673659B2 (en) 1991-11-25 1996-11-21 Institute Of Molecular Biology, Inc. Medicament for promoting growth of mammalian nerve
AU4930299A (en) 1998-07-31 2000-02-21 Kirin Beer Kabushiki Kaisha Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
WO2008112170A1 (en) * 2007-03-09 2008-09-18 Corning Incorporated Three dimensional gum matrices for cell culture, manufacturing methods and methods of use
JP6010460B2 (ja) * 2009-08-25 2016-10-19 セルビシオ アンダルス デ サルＳｅｒｖｉｃｉｏ Ａｎｄａｌｕｚ Ｄｅ Ｓａｌｕｄ フィブリンおよびアガロース生体材料を用いる組織工学による、人工組織の製造
KR20110023399A (ko) * 2009-08-31 2011-03-08 한국과학기술연구원 지혈효과 및 기계적 물성이 우수한 지능형 피브린 생체접착제
US9074095B2 (en) * 2010-06-03 2015-07-07 Technology Innovation Momentum Fund (Israel) Limited Partnership Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
EP2594295A1 (en) * 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nerve implants based on a compacted biomaterial containing cells
CN102688525B (zh) * 2012-05-07 2013-11-27 东南大学 一种生物大分子水凝胶及其制备方法
CN103908693B (zh) * 2014-04-15 2015-10-28 山东颐诺生物科技有限公司 一种仿生型海藻酸基复合抗菌敷料及其制备方法

Also Published As

Publication number Publication date
BR112017008117B1 (pt) 2020-12-08
KR20170073673A (ko) 2017-06-28
CA2964501C (en) 2023-05-16
US20170340771A1 (en) 2017-11-30
BR112017008117A2 (pt) 2018-02-20
AU2015334897B2 (en) 2019-08-01
EP3011981A1 (en) 2016-04-27
JP6633628B2 (ja) 2020-01-22
JP2017531533A (ja) 2017-10-26
WO2016062862A1 (en) 2016-04-28
AU2015334897A1 (en) 2017-05-18
CA2964501A1 (en) 2016-04-28
CN107073170A (zh) 2017-08-18
CN107073170B (zh) 2021-06-29
ES2774792T3 (es) 2020-07-22
EP3209341A1 (en) 2017-08-30
KR102489773B1 (ko) 2023-01-17
MX380173B (es) 2025-03-12
EP3209341B1 (en) 2020-01-01
US11241516B2 (en) 2022-02-08

Similar Documents

Publication Publication Date Title
MX2017005373A (es) Soporte de biomaterial para la regeneracion de mucosa oral.
ECSP17078433A (es) Composiciones de ácido obeticólico y métodos de uso
NI201800072A (es) 3 - azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
PH12017502283A1 (en) A method of treatment
MX2016013034A (es) Composicion detergente.
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
EA201790398A1 (ru) Способы лечения заболевания печени
MX372723B (es) Métodos para marcar una molécula deuterada o no deuterada y formulaciones farmacéuticas para tratamiento.
BR112017013691A2 (pt) composição compreendendo um polímero em multiestágio, seu método de preparação e seu uso
AR079889A1 (es) Antagonistas de wnt y metodos de tratamiento y deteccion
MX366317B (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
CY1122615T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες τουενδομητριου
BR112017000022A2 (pt) nanoparticulas terapêuticas direcionadas a alvo e métodos de produção e uso dessas partículas
CL2020000734A1 (es) Expansión y uso de fracciones de células nk ampliadas.
MX382116B (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX395667B (es) Caucho natural resistente a la oxidacion y metodo para su produccion.
UY36173A (es) Metodo de tratamiento de enfermedades relacionadas con el factor inducible por hipoxia
EP3525271A4 (en) METHOD FOR MANUFACTURING ELECTRODE CATALYST, AND ELECTRODE CATALYST
MX386743B (es) Métodos para transformación de plástidos.
EP3915565A3 (en) Xanthine oxidase inhibitor formulations
CO2017012397A2 (es) Fragmento de anticuerpo fab anti-ngf humano
AR051144A1 (es) Procedimiento para formar atorvastatina amorfa
CL2017000560A1 (es) Fórmula que incluye glicopirrolato, método y sistema
MX2018006577A (es) Metodo para inactivar xenoantigenos en tejidos biologicos.